Immune thrombocytopenia: A retrospective study of 40 patients;Traitement du purpura thrombopénique immunologique: Étude rétrospective de 40 patients

Revue de Medecine Interne

Volumn 31, Issue 5, 2010, Pages 337-344

  Audia, S ^a   Lakomy, D ^b   Guy, J ^c   Leguy Seguin, V ^a   Berthier, S ^a   Aho, S ^d   Lorcerie, B ^a   Bonnotte, B ^a  

^a HÔPITAL DU BOCAGE   (France)

^b Laboratoire d'immunologie   (France)

^c Service d'Hematologie   (France)

^d Medical University of Dijon   (France)

Author keywords

Dapsone; Immune thrombocytopenia; Rituximab; Steroids

Indexed keywords

CORTICOSTEROID; DAPSONE; FIBRINOGEN RECEPTOR; PREDNISONE; RITUXIMAB; THROMBOCYTE ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; RELAPSE; RETROSPECTIVE STUDY; SPLENECTOMY; THROMBOCYTE COUNT;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTIBODIES, MONOCLONAL; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SPLENECTOMY; TREATMENT OUTCOME;

EID: 77952551171     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.11.008     Document Type: Article

References (39)

1. Abrahamson P.E., Hall S.A., Feudjo-Tepie M., Mitrani-Gold F.S., Logie J. The incidence of idiopathic thrombocytopenic purpura (ITP) among adults: A population-based study and literature review. Eur J Haematol 2009.
2. Segal J.B., Powe N.R. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 2006, 4:2377-2383.
3. Audia S, Lorcerie B, Godeau B, Bonnotte B. Physiopathologie du purpura thrombopénique immunologique. Rev Med Interne 2009; (sous presse).
4. Portielje J.E., Westendorp R.G., Kluin-Nelemans H.C., Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001, 97:2549-2554.
5. Cines D.B., Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med 2002, 346:995-1008.
6. Frederiksen H., Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999, 94:909-913.
7. Aledort L.M., Hayward C.P., Chen M.G., Nichol J.L., Bussel J. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol 2004, 76:205-213.
8. Kuwana M., Okazaki Y., Satoh T., Asahi A., Kajihara M., Ikeda Y. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med 2005, 118:1026-1033.
9. Rinder H.M., Tracey J.B., Recht M., DeCastro L., Rinder C.S., McHugh C., et al. Differences in platelet alpha-granule release between normals and immune thrombocytopenic patients and between young and old platelets. Thromb Haemost 1998, 80:457-462.
10. Latorraca A., Lanza F., Moretti S., Ferrari L., Reverberi R., Galluccio L., et al. Flow cytometric analysis of antiplatelet antibodies in idiopathic thrombocytopenic purpura. Haematologica 1994, 79:269-272.
11. Stockelberg D., Hou M., Jacobsson S., Kutti J., Wadenvik H. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA. Eur J Haematol 1996, 56:72-77.
12. Rosenfeld C.S., Nichols G., Bodensteiner D.C. Flow cytometric measurement of antiplatelet antibodies. Am J Clin Pathol 1987, 87:518-522.
13. Kiefel V., Santoso S., Weisheit M., Mueller-Eckhardt C. Monoclonal antibody - specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987, 70:1722-1726.
14. Brighton T.A., Evans S., Castaldi P.A., Chesterman C.N., Chong B.H. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 1996, 88:194-201.
15. British committee for standards in haematology general haematology task force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-96.
16. Soupir C.P., Vergilio J.A., Kelly E., Dal Cin P., Kuter D., Hasserjian R.P. Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura. Br J Haematol 2009, 144:800-802.
17. Abbasi S.Y., Milhem M., Zaru L. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura. Ann Hematol 2008, 87:459-462.
18. Altintas A., Ozel A., Okur N., Okur N., Cil T., Pasa S., et al. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 2007, 24:163-168.
19. Vantelon J.M., Godeau B., Andre C., Bierling P. Screening for auto-immune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no auto-immune markers at onset. Thromb Haemost 2000, 83:42-45.
20. Godeau B., Provan D., Bussel J. Immune thrombocytopenic purpura in adults. Curr Opin Hematol 2007, 14:535-556.
21. Stasi R., Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 2004, 79:504-522.
22. Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D.M., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009, 113:2386-2393.
23. Damodar S., Viswabandya A., George B., Mathews V., Chandy M., Srivastava A. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults - a report on 90 patients. Eur J Haematol 2005, 75:328-331.
24. Godeau B., Durand J.M., Roudot-Thoraval F., Tenneze A., Oksenhendler E., Kaplanski G., et al. Dapsone for chronic auto-immune thrombocytopenic purpura: a report of 66 cases. Br J Haematol 1997, 97:336-339.
25. Cappellini M.D., Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008, 371:64-74.
26. Maloisel F., Andres E., Zimmer J., Noel E., Zamfir A., Koumarianou A., et al. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results. Am J Med 2004, 116:590-594.
27. Daou S., Federici L., Zimmer J., Maloisel F., Serraj K., Andres E. Idiopathic thrombocytopenic purpura in elderly patients: a study of 47 cases from a single reference center. Eur J Intern Med 2008, 19:447-451.
28. Nomura T., Maekawa T., Uchino H., Miyazaki T., Miura Y., Abe T., et al. Clinical usefulness of vinca alkaloid slow infusion in the treatment of chronic refractory idiopathic thrombocytopenic purpura: a multicenter cooperative study. Nippon Ketsueki Gakkai Zasshi 1990, 53:98-104.
29. Facon T., Caulier M.T., Wattel E., Jouet J.P., Bauters F., Fenaux P. A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients. Br J Haematol 1994, 86:678-680.
30. Arnold D.M., Dentali F., Crowther M.A., Meyer R.M., Cook R.J., Sigouin C., et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007, 146:25-33.
31. Godeau B., Porcher R., Fain O., Lefrere F., Fenaux P., Cheze S., et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura - results of a prospective multicenter phase 2 study. Blood 2008.
32. Agence française de sécurité sanitaire des produits de santé. Référentiel de bon usage du rituximab. 2008: http://www.afssaps.fr/var/afssaps_site/storage/original/application/bb7855682c373819754203f89b41e63d.pdf.
33. Roll P., Palanichamy A., Kneitz C., Dorner T., Tony H.P. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum 2006, 54:2377-2386.
34. Roll P., Dorner T., Tony H.P. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment. Arthritis Rheum 2008, 58:1566-1575.
35. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., et al. Human blood IgM " memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004, 104:3647-3654.
36. Martinez-Gamboa L., Mei H., Loddenkemper C., Ballmer B., Hansen A., Lipsky P.E., et al. Role of the spleen in peripheral memory B-cell homeostasis in patients with auto-immune thrombocytopenia purpura. Clin Immunol 2009, 130:199-212.
37. Kojouri K., Vesely S.K., Terrell D.R., George J.N. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004, 104:2623-2634.
38. Johansson E., Engervall P., Landgren O., Grimfors G., Widell S., Rezai S., et al. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura. Eur J Haematol 2006, 77:61-66.
39. Dolan J.P., Sheppard B.C., DeLoughery T.G. Splenectomy for immune thrombocytopenic purpura: surgery for the 21st century. Am J Hematol 2008, 83:93-96.